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Background: The purpose of this study was to evaluate the impact of Cone Beam CT (CBCT) based setup
correction on total dose distributions in fractionated frameless stereotactic radiation therapy of intracranial lesions.
Methods: Ten patients with intracranial lesions treated with 30 Gy in 6 fractions were included in this study.
Treatment planning was performed with Oncentra® for a SynergyS® (Elekta Ltd, Crawley, UK) linear accelerator with
XVI® Cone Beam CT, and HexaPOD™ couch top. Patients were immobilized by thermoplastic masks (BrainLab,
Reuther). After initial patient setup with respect to lasers, a CBCT study was acquired and registered to the planning
CT (PL-CT) study. Patient positioning was corrected according to the correction values (translational, rotational)
calculated by the XVI® system. Afterwards a second CBCT study was acquired and registered to the PL-CT to
confirm the accuracy of the corrections. An in-house developed software was used for rigid transformation of the
PL-CT to the CBCT geometry, and dose calculations for each fraction were performed on the transformed CT. The
total dose distribution was achieved by back-transformation and summation of the dose distributions of each
fraction. Dose distributions based on PL-CT, CBCT (laser set-up), and final CBCT were compared to assess the
influence of setup inaccuracies.
Results: The mean displacement vector, calculated over all treatments, was reduced from (4.3 ± 1.3) mm for laser
based setup to (0.5 ± 0.2) mm if CBCT corrections were applied. The mean rotational errors around the medial-lateral,
superior-inferior, anterior-posterior axis were reduced from (−0.1 ± 1.4)°, (0.1 ± 1.2)° and (−0.2 ± 1.0)°, to (0.04 ± 0.4)°,
(0.01 ± 0.4)° and (0.02 ± 0.3)°. As a consequence the mean deviation between planned and delivered dose in the
planning target volume (PTV) could be reduced from 12.3% to 0.4% for D95 and from 5.9% to 0.1% for Dav. Maximum
deviation was reduced from 31.8% to 0.8% for D95, and from 20.4% to 0.1% for Dav.
Conclusion: Real dose distributions differ substantially from planned dose distributions, if setup is performed according
to lasers only. Thermoplasic masks combined with a daily CBCT enabled a sufficient accuracy in dose distribution.
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Table 1 Dose prescription and normalization for each
localization
Localization Normalized Percent
1 Average of PTV 100
2 Average of PTV 100
3 Maximum of PTV 90
4 Average of PTV 100
5 Maximum of PTV 90
6 Maximum of PTV 90
7 Isocenter 100
8 Average of PTV 100
9 Maximum of GTV 90
10 Maximum of GTV 90
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In stereotactic radiation therapy a steep dose gradient is
required to spare healthy tissue. As a consequence pa-
tient setup has to be highly precise and reproducible.
During the last years, on board Cone Beam CT (CBCT)
systems became commercially available for accurate pa-
tient positioning and made frameless stereotactic radi-
ation therapy (SRT) possible. The advantage of SRT as
compared to frame based systems is the fast setup pro-
cedure with better patient comfort. Previous studies in-
vestigated the magnitude of setup errors depending on
different positioning systems [1-4]. Boda-Heggeman
et al. [1] analysed differences in accuracy between rigid
and thermoplastic (TP) mask systems. Rotational and
translational displacements were investigated. TP masks,
in combination with CBCT, reached similar accuracy as
rigid mask systems. Gilbeau L et al. [2] compared the
setup accuracy of different TP masks. The investigation
was performed by use of portal imaging. No substantial
difference between the masks was found. Tryggestad
et al. [4] evaluated setup accuracy of four frameless TP
mask systems using daily CBCT. All mask systems ex-
amined within this study were regarded as suitable for
SRT, if daily CBCT was performed. A quality assessment
of SRT by means of two different CBCT was performed
by Peng et al. [3]. The impact of setup errors on the
daily and total dose distribution in the patient was, how-
ever, not subject of these studies.
The influence of rotational setup errors to generalized
equivalent uniform dose (gEUD) was evaluated by
Beltran et al. [5] for three cases of pediatric brain tu-
mours. Rotational errors were considered by alteration
and recalculation of the initial treatment plan (TPL), to
simulate rotations of 2° and 4° around each cardinal dir-
ection separately. Rotation of 2° changed gEUD values of
planning target volumes (PTV) and organs at risk
(OAR) less than 2%. Rotations of 4° led to the same re-
sult to parallel type normal structures, whereas in case
of serial type normal structures and PTV the gEUD
values changed by 5% and 10%. Consequently a correc-
tion of rotational errors of more than 2° was advised.
Guckenberger et al. [6] found only a small influence of
setup error to dose, if the tumour was located in base of
skull. Deviation in dose was less than 5%. A recent re-
port investigated dosimetric influence of translational
and rotational setup errors to dose by single fraction
SRT [7]. Result of this study is a need of accuracy of
1 mm or less to avoid a decreased target coverage and a
loss of dose conformity > 5% with respect to TPL.
In case of fractionated SRT daily uncertainties add up
and may cause deviations in the dose distribution com-
pared to TPL. In contrary to single fraction SRT, random
errors in setup may lead to a more shallow dose gradi-
ent, whereas systematic errors cause a shift and rotationof the dose distribution. The aim of this study was to in-
vestigate the influence of laser and CBCT based setup
technique on the total dose in fractionated SRT.
Methods and material
Patients and dose prescription
Data of 10 intracranial lesions were retrospectively eval-
uated in this study. Dose prescription was individually
adapted to clinic (Table 1).
Treatment unit and treatment planning system (TPS)
The treatment unit consists of a SynergyS® (Elekta Ltd,
Crawley, UK) linear accelerator with a BeamModulator™
head, leaf width of 4 mm at isocenter. For image guided
radiation therapy (IGRT), a XVI® Cone Beam CT
(CBCT) and a HexaPOD™ couch top in connection with
software iGuide® Ver.R1.1.Rev1 (Medical Intelligence,
Schwabmünchen, Germany) were used. Dose calcula-
tions were performed in Oncentra® External Beam v4.0
SP1 (Nucletron BV, Veenendaal, Netherlands) (OMP)
with a pencil beam algorithm. Beam quality was 6MV.
Immobilization and setup protocol
Patients were immobilized using a stereotactic TP mask
system (BrainLab) or TP mask system (Reuther). After
initial patient setup with respect to lasers, a CBCT study
was acquired and registered to the planning CT study.
Translational deviations in medial-lateral, superior-inferior,
anterior-posterior direction (Δx, Δy, Δz) and rotational de-
viations around x, y, z (Δα, Δβ, Δγ) were calculated by the
XVI® software. Rotational and translational displacement
was corrected. A second CBCT study was acquired and
the actual deviation was determined.
Evaluation of setup errors
Setup deviation after laser setup and CBCT was recorded
for each fraction in 6 degrees of freedom. The absolute
values of the translational displacement vectors were
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calculated as the mean setup error and its standard devi-
ation (SD) [8] for each patient over all fractions for a)
setup to lasers only and b) CBCT corrected patient setup.
The group systematic error, the mean of all means and the
group mean of the SD (random error) calculated as the
root mean square of the SD’s of all patients [8] were deter-
mined as well.
Transformation of DICOM data
For assessment of the dose distribution achieved when
residual translational and rotational setup errors are
present after patient setup, the planning CT data were
transformed according to the setup errors calculated by
the XVI system for all therapy fractions. For each fraction,
the original TPL was then recalculated on the transformed
CT data set, resulting in a dose distribution of the fraction.
The total dose distribution is then achieved by inverse
transformation and summation of the dose distributions
of each fraction.
DICOM data can in principle be transformed by a
transformation of the reference coordinate system. Since
Oncentra®, however, does not allow the import of CT
data with a rotated reference coordinate system, the
DICOM data had to be transformed keeping the original
reference coordinate system. This was achieved by target
to source mapping to avoid voids in the target image [9].
An empty CT cube is created and for each voxel the cor-
responding coordinates in the source image are deter-
mined by inverse transformation of the voxel coordinate.
The grey value is calculated from the neighbouring
voxels of the source coordinate by trilinear interpolation,
the expansion of bilinear interpolation to three dimen-
sions [9,10]. The dose distribution for each fraction is
then calculated on the corresponding transformed CT
cube and stored in a dose cube. To be able to calculate
the cumulative dose distribution for all fractions, the
dose cubes of each fraction are transformed back to the
original geometry such, that all fractional dose cubes are
of the same size and resolution. The dose cubes are then
summed up by summation of the corresponding dose
values of each individual voxel to achieve the cumula-
tive dose value over all fractions. The cumulative dose
cube can then be imported to the original planning CT
in Oncentra® for comparision with the planned dose
distribution.
The geometrical transformation has been validated on
a geometrical cubical phantom with asymetric rods in-
serts, which was originally designed for quality assurance
of patient positioning by CBCT. Registration of the
transformed CT data with the planning CT in XVI con-
firmed the values used for translation and rotation of the
data cube. The influence of the interpolation on the final
dose distribution depends on the slope in grey values ofthe CT data used. It was tested on sample patient CT
data as follows: In Oncentra a transformation of the CT
data was simulated by a translation of the isocenter of
the treatment plan of −1.0 cm in each direction and a
rotation of the couch and the gantry around −4.0° to
simulate a rotation around the cranio-caudal and the
ventro-dorsal axis. A rotation around the third axis can-
not be simulated in Oncentra and is therefore not taken
into account. The corresponding translation of 1.0 cm
and 4.0° rotation of the CT data was performed using
the in-house software. The resulting CT data set was
imported in Oncentra for recalulation of the plan. The
dose distributions achieved with the two methods were
compared in the evaluation software OmniPro-I’mRT
(IBA Dosimetry, Schwarzenbruck, Germany) for the CT
slices in the high dose region. For all slices absolute
values of the dose differences were within 0.4% ± 1.1%.
Evaluation of impact to dose
The total dose distributions which would be achieved
with setup to light markers only and which are achieved
with CBCT based set up were then compared to the ori-
ginal dose distribution of the TPL. For the PTV D95
(dose to 95% of PTV), D05 (dose to 5% of PTV), and Dav
(average dose to PTV) were evaluated. To quantify
changes in dose distribution in spite of different
normalization, relative deviations to the corresponding
TPL were calculated and compared. For assessment of
how well the prescription dose conforms to the size and
the shape of the target, the Paddick conformity index
CIPTV [11] was calculated by CIPTV = (PTVPD/PTV) *
(PTVPD/VolPD), with the volume of PTV treated with
the prescription dose PTVPD, and the total volume re-
ceiving the prescription dose VolPD. The ideal, i.e. most
conformal TPL has a CIPTV of 1. The lower the value of
CIPTV, the larger is the mismatch between VolPD and
PTV, i.e. the less conformal the plan.
A comparison of the dose to certain organs at risk
(OAR) over all tumour localizations was not consid-
ered meaningful because of the different distances of




The use of CBCT decreased the displacement vector
(overall mean ± SD) from (4.3 ± 1.3) mm to (0.5 ± 0.2)
mm as compared to laser setup.
Average setup error and SD for each lesion in case of
laser setup and CBCT is demonstrated in Figure 1.
After laser setup a maximum translational systematic
displacement of 4.7 mm was measured in y direction
(localization 3). The random error in this case and dir-
ection was 5.3 mm. The maximum rotational systematic
Figure 1 Average translational (left) and rotational (right) setup error and SD for each lesion for laser based (top) and CBCT based
(bottom) patient setup.
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error of 1.3°. The systematic and random error was de-
creased after CBCT below 1 mm and 0.6° (Figure 1).
The group systematic error, group mean of SD and max-
imum displacement over all localizations are presented in
Table 2.
Impact on dose distribution
Setup errors for a) patient setup according to lasers only
and b) CBCT based setup correction lead to differences in
dose distribution as compared to the original TPL. The
average Paddick conformity index CIPTV changed from
0.67 (min 0.48/max 1.02) in the TPL to 0.39 (min 0.00/
max 0.99) for laser based set up, and to 0.65 (min 0.44/Table 2 Group systematic error (overall mean), group mean S
Laser setup
Group mean Group SD M
x (mm) −1.7 1.4
y (mm) 0.3 3.0
z (mm) −0.2 1.2
α (degree) −0.1 0.9 −
β (degree) 0.1 0.7
γ (degree) −0.2 0.8 −max 0.94) for CBCT based setup. Results for PTV param-
eters D95, D05 and Dav are listed in Table 3. For setup to
light markers only, D95 and Dav decrease substantially,
with a maximum deviation of −31.8% (D95), -20.4% (Dav),
and −17.7% (D05). For CBCT based setup correction
only small deviations up to −0.8% (D95), -0.4% (Dav),
and −3.9% (D05) can be observed. Most sensitive to dis-
placements resulting from setup to lasers was D95 with a
mean deviation of −12.3% followed by Dav with a mean
deviation of −5.9%. If setup was corrected based on CBCT
data, these values were clearly reduced to a mean devi-
ation of −0.4% in D95 and −0.1% in Dav.The influence of
displacement on dose to OAR depends on the distance be-
tween OAR and PTV and on the dose gradient. GenerallyD and maximum displacement
CBCT setup
ax Group mean Group SD Max
5.5 −0.1 0.4 2.0
9.5 −0.2 0.4 1.6
4.4 0.0 0.3 1.1
3.1 0.0 0.4 1.3
4.2 0.0 0.3 1.2
3.7 0.0 0.3 0.8
Table 3 Impact on setup technique on D95, D05 and Dav of
the PTV as compared to the original treatment plan
PTV Laser setup CBCT setup
D95 D05 Dav D95 D05 Dav
mean −12.3% −3.9% −5.9% −0.4% −0.5% −0.1%
max −31.8% −17.7% −20.4% −0.8% −3.9% −0.4%
min −1.7% −0.2% −0.5% 0.2% 0.2% 0.4%
Changes are given in % of the respective dose value of the treatment plan,
negative values represent a dose reduction and positive values an increase.
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to OAR. Because the initial doses to OAR were low, abso-
lute dose deviations were negligible. As an example, the
dose volume histogram (PL-CT, Laser and CBCT) for
localization 9 is presented in Figure 2.
Discussion
One base of successful stereotactic radiation therapy
of intracranial lesions is a reliable patient setup.
Intrafractional and interfractional changes in patient
setup have to be considered. Intrafractional changes
arise from patient motion during treatment. Initially
invasive stereotactic frames for rigid immobilisation
together with localizers were used for single fraction
stereotactic radiation therapy [12]. Stereotactic TP mask
systems including localizers were used for fractionated ra-
diation therapy [4]. Both methods were time consuming
and uncomfortable for patients. Guckenberger et al.
proposed the use of the bony structures of skull instead of
localizer, to determine the target position. Comparison
of bony registration (CBCT) and soft-tissue match using
a mobile CT showed a highly significant correlation for
brain metastases [13]. TP masks were evaluated with
respect to positioning uncertainties. Several investiga-
tions were performed to determine interfractional and
intrafractional uncertainties using TP masks combinedFigure 2 DVH comparison for a typical case: The continuous line repr
to lasers, and the dotted line setup based on CBCT.with CBCT [1,4,13-15]. Mean displacement values and
corresponding SD for TP masks in case of laser setup
evaluated in our study agreed with the data presented in
[1] (4.7 mm ± 1.7 mm) and [13] (4.6 mm ± 2.1 mm).
All these studies showed that setup deviations can be
reduced but not completely avoided by the use of
immobilization devices in combination with CBCT cor-
rection. It is therefore necessary to assess the impact of
these residual setup deviations on dose distribution. For
single fraction SRT, this has been performed by
Guckenberger et al. [7], who determined a loss of dose
conformity measured by CIPTV with 0.73 for TPL to 0.43
for laser set up and to 0.73 for CBCT based set up. In
this case the impact of residual setup errors is negligible
for CBCT based setup but not for laser based setup.
The scope of our study was to evaluate the influence
of setup errors on the dose distribution in fractionated
stereotactic treatments. In contrary to single fraction
SRT, where all kinds of setup errors lead basically to a
shift and rotation of the dose distribution, this is only
the case for systematic errors in fractionated SRT. Ran-
dom errors cause a broadening in dose fall off, because
dose distributions of all fractions are combined to the
total dose. It could be shown, that patient setup based
on light markers only would lead to a substantial loss of
dose coverage in the PTV even in fractionated SRT,
whereas patient setup using CBCT resulted in minor de-
viations as compared to the TPL, with a CIPTV of 0.67
for the TPL, 0.36 for laser set up, and 0.65 for CBCT
based setup. These results confirm the importance of
CBCT even in case of fractionated frameless SRT.
Conclusion
Real total dose distributions in fractionated SRT differ
substantially from planned dose distributions, if setup is
performed according to lasers only. Frameless fractionatedesents the original TPL, the dashed line patient setup according
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CBCT enables an agreement between planned and de-
livered dose to PTV within 1% for D95 and Dav.
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